Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China.
Department of Vascular Surgery, The Second Affiliated Hospital of Nanchang University, People's Republic of China.
Obes Res Clin Pract. 2020 Jul-Aug;14(4):368-374. doi: 10.1016/j.orcp.2020.06.005. Epub 2020 Jul 4.
Scutellarein (Sc), a natural compound and an active ingredient of Erigeronbrevis-capus (Vant.), shows anti-obesity, anti-inflammation and lipid-lowering properties in our previous study. However, no previous in vivo and vitro has been conducted to assess the effects of Sc in insulin resistance (IR). This study investigated the effects of Sc on IR and oxidative stress and explored the underlying mechanisms of action in vivo and vitro.
A well-established mouse model of IR, induced by high-fat diet (HFD) feeding, was applied in this study. The effects of Sc were evaluated on obesity, glycometabolism disorder and oxidative stress. The anti-IR effect was assessed using blood glucose, serum insulin, HOMA index, intraperitoneal glucose tolerance tests (IPGTT), intraperitoneal insulin tolerance tests (IPITT), and glucose-regulating enzyme activity. The insulin signaling pathways and AMPKα expressions were tested by Western blot. The primary culture of hepatocytes was prepared and used for confirming the above signaling pathways.
Obesity, IR and oxidative stress developed in HFD mice. Administration of Sc at a dose of 50mg/kg for 16 weeks effectively attenuated these changes. Further studies revealed the antagonistic effect of Sc on IR was a result of the activation of the insulin signaling pathway and AMPKα. The primary hepatocyte test, stimulated by high glucose, further confirmed that SC exerts anti-IR through the above signaling pathway and key protein.
These results suggested that Sc possesses not only an important novel anti-IR effect but also an anti-oxidative stress effect. These favorable effects were causally associated with weight loss and the improved glycometabolism. The underlying mechanisms might associated with the activation of the insulin signaling pathway and AMPKα. Our study promotes the understanding of the pharmacological actions of Sc, and plays a role for Sc in the effective treatment of diabetes mellitus.
野黄芩苷(Sc)是一种天然化合物,也是短葶飞蓬(Vant.)的一种活性成分,在我们之前的研究中显示出抗肥胖、抗炎和降血脂的特性。然而,目前还没有体内和体外研究评估 Sc 对胰岛素抵抗(IR)的影响。本研究旨在评估 Sc 对 IR 和氧化应激的影响,并探讨其在体内和体外的作用机制。
本研究采用高脂饮食(HFD)喂养诱导的肥胖 IR 小鼠模型。评估 Sc 对肥胖、糖代谢紊乱和氧化应激的影响。通过血糖、血清胰岛素、HOMA 指数、腹腔葡萄糖耐量试验(IPGTT)、腹腔胰岛素耐量试验(IPITT)和葡萄糖调节酶活性评估 Sc 的抗 IR 作用。通过 Western blot 检测胰岛素信号通路和 AMPKα 表达。采用原代肝细胞培养法进一步验证上述信号通路。
HFD 喂养的小鼠出现肥胖、IR 和氧化应激。Sc 以 50mg/kg 的剂量给药 16 周可有效减轻这些变化。进一步的研究表明,Sc 拮抗 IR 的作用是通过激活胰岛素信号通路和 AMPKα 实现的。高糖刺激的原代肝细胞试验进一步证实,Sc 通过上述信号通路和关键蛋白发挥抗 IR 作用。
这些结果表明,Sc 不仅具有重要的新型抗 IR 作用,还具有抗氧化应激作用。这些有利作用与体重减轻和改善糖代谢有关。其潜在机制可能与胰岛素信号通路和 AMPKα 的激活有关。本研究促进了对 Sc 药理作用的理解,为 Sc 在糖尿病的有效治疗中发挥作用提供了依据。